首页> 外文期刊>American journal of clinical dermatology >Subcorneal Pustular Dermatosis (Sneddon-Wilkinson Disease) with Absence of Desmoglein 1 and 3 Antibodies Case Report and Literature Review
【24h】

Subcorneal Pustular Dermatosis (Sneddon-Wilkinson Disease) with Absence of Desmoglein 1 and 3 Antibodies Case Report and Literature Review

机译:缺乏桥粒芯蛋白1和3抗体的角膜下脓疱性皮肤病(Sneddon-Wilkinson病)病例报告和文献复习

获取原文
获取原文并翻译 | 示例
           

摘要

Subcorneal pustular dermatosis (SPD) [Sneddon-Wilkinson disease] is a benign and uncommon disorder characterized by a chronic, relapsing vesiculopustular eruption of unknown etiology. We present a case of SPD in a young Black woman in whom ELISA was performed to test for desmoglein 1 and 3 antigens (the first reported case of evaluation for these antigens in a patient with SPD). The test revealed the absence of both antibodies. The patient was successfully treated with topical corticosteroids and narrow-band UVB phototherapy.In this report, we review both the pathophysiology of SPD, which has yet to be clarified, and its treatment. Data obtained from our case report add further support to the hypothesis that a non-antibody-mediated mechanism is operative in SPD. The treatment of choice for SPD is dapsone. However, the combination of corticosteroids and UVB phototherapy should be considered a valid therapeutic option in patients who are not appropriate candidates for dapsone therapy.
机译:角膜下脓疱性皮肤病(SPD)[Sneddon-Wilkinson病]是一种良性且罕见的疾病,其特征是病因不明的慢性复发性膀胱小泡疹。我们介绍了一名年轻的黑人妇女的SPD病例,在该妇女中进行了ELISA测试以检测桥粒芯糖蛋白1和3抗原(在SPD患者中首次报道了评估这些抗原的病例)。该测试表明两种抗体均不存在。该患者已成功应用局部糖皮质激素和窄带UVB光疗治疗。在本报告中,我们回顾了尚待阐明的SPD的病理生理及其治疗方法。从我们的病例报告中获得的数据进一步支持了SPD中非抗体介导的机制起作用的假说。 SPD的首选治疗方法是氨苯砜。但是,对于不适合氨苯砜治疗的患者,应将皮质类固醇和UVB光疗相结合被认为是有效的治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号